May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Treatment of Retinal Angiomatous Proliferations (RAP). An interventional case series.
Author Affiliations & Notes
  • F. Bottoni
    Ophthalmology Dept, S Giuseppe Hospital, Milan, Italy
  • A. Massacesi
    Ophthalmology Dept, S Giuseppe Hospital, Milan, Italy
  • M. Cigada
    Ophthalmology Dept, S Giuseppe Hospital, Milan, Italy
  • F. Viola
    Institute of Ophthalmology, University of Brescia, Brescia, Italy
  • G. Staurenghi
    Institute of Ophthalmology, University of Brescia, Brescia, Italy
  • Footnotes
    Commercial Relationships  F. Bottoni, None; A. Massacesi, None; M. Cigada, None; F. Viola, None; G. Staurenghi, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3102. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F. Bottoni, A. Massacesi, M. Cigada, F. Viola, G. Staurenghi; Treatment of Retinal Angiomatous Proliferations (RAP). An interventional case series. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3102.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To report the management of RAP, a recently described intraretinal neovascular lesion that occurs in age–related macular degeneration (AMRD). Methods: We retrospectively reviewed the charts of 73 consecutive patients with ARMD who were affected by 100 RAPs evaluated at the two study centers. Diagnosis of RAP was based on dynamic ICG angiography (SLO,HRA–Heidelberg Engineering, Germany) and each lesion was cathegorized into three different stages as recently suggested (Yannuzzi LA et al, Retina, 2001; 21:416). Four treatment modalities were performed: direct laser photocoagulation of the vascular lesion, laser photocoagulation of the feeder retinal arteriole, scatter "grid–like" laser photocoagulation and photodynamic therapy (PDT). The clinical data were statistically analyzed (ANOVA) to obtain two main outcome measures: complete obliteration of the lesion and final visual acuity (VA). Results: Overall, 41 RAPs were at stage I, 39 at stage II and 20 at stage III. Stage I: A complete obliteration was achieved in 16 out of 21 lesions (76%) submitted to direct laser photocoagulation (final VA: ≥ 0.3, 15 eyes; ≤ 0.1, 5 eyes), compared to 7 out of 11 lesions (64%) managed with PDT (final VA: ≥ 0.3, 6 eyes; ≤ 0.1, 4 eyes) and 3 out of 6 lesions (50%) treated with scatter "grid–like" laser photocoagulation (final VA: ≥ 0.3, none; ≤ 0.1, 3 eyes). Stage II: : A complete obliteration was achieved in 2 out of 11 lesions (18%) submitted to direct laser photocoagulation (final VA: ≥ 0.3, 5 eyes; ≤ 0.1, 6 eyes), compared to 2 out of 7 lesions (29%) managed with PDT (final VA: ≥ 0.3, none; ≤ 0.1, 4 eyes) and 5 out of 13 lesions (38%) treated with scatter "grid–like" laser photocoagulation (final VA: ≥ 0.3, 1 eye; ≤ 0.1, 10 eyes). Stage III: no treatment benefit was recorded with a final VA ≤ 0.1 in every eye. Initial VA (P=0,01) and stage of the lesion (P=0,003) were predictors of final VA with good presenting VA and earlier stages (I) being associated with better functional outcomes. Conclusion: Early detection of the lesion and subsequent direct conventional laser photocoagulation seems to be associated with better anatomical and functional outcomes. Once the vascular complex is well established, anatomical closure is rarely achieved with any treatment modality.

Keywords: clinical (human) or epidemiologic studies: outcomes/complications • age–related macular degeneration • retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×